SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is trending due to its upcoming inclusion in the Nasdaq-100 index, which is fueling significant buying pressure and speculation as investors anticipate forced demand from index funds. The community remains deeply divided, with many debating whether the stock is undergoing an unprecedented AI-driven growth cycle or if it has reached a precarious valuation peak as it approaches the 1,000 mark.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as investors speculate on potential early FDA approval for Deramiocel and the expected appointment of a new CBER director. The community is actively discussing rumors regarding the hiring of a former company VP to a high-level FDA role and remains bullish on the company's long-term prospects despite recent price volatility.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal is currently capturing attention as market participants analyze a potential re-rating driven by aggressive share buybacks, a massive undervaluation relative to its free cash flow, and persistent buyout rumors involving major tech players. While the stock has remained in a long-term consolidation range, the community is actively debating the upcoming strategic vision of the new CEO, with many investors anticipating that impending operational updates or potential consolidation will finally break the stock out of its current sideways pattern.

Nokia Oyj engages in the provision of network infrastructure, technology, and software services. It operates through the following segments: Mobile Networks, Network Infrastructure, Cloud and Network Services, and Nokia Technologies. The Mobile Networks segment offers technologies for Radio Access Networks (RAN) as well as Microwave Radio Links (MWR) for transport networks. The Network Infrastructure serves communication service providers, enterprises, webscales and public sector customers. The Cloud and Network Services segment builds around software and the cloud and is focused on driving leadership in cloud-native software and as-a-service delivery models, as demand for critical networks accelerates; and with strong market positions in communications software, private wireless networks, and cognitive (or intelligent) services. The Nokia Technologies segment, building on decades of innovation and R&D leadership in technologies used in virtually all mobile devices used today, is expanding the Nokia patent licensing business, reintroducing the Nokia brand to smartphones through brand licensing, and establishing a technology licensing business. The company was founded by Fredrik Idestam in 1865 and is headquartered in Espoo, Finland.

Nokia Corp - ADR

Nokia Corp

Nokia is trending as investors focus on its pivot toward AI infrastructure and optical networking, fueled by key partnerships with major industry players and recent government defense contract awards. The community is actively discussing the stock's potential for a multi-year growth trajectory, with many comparing its current positioning to other high-performing tech infrastructure firms.

RaveDAO is a global community uniting music, technology, and purpose. Since their first sold-out event at Dubai 2024, they have expanded across Europe, the Middle East, North America, and Asia, hosting world-class experiences with over 100,000 total attendees and 3,000+ attendees for each event.  RaveDAO has worked with top-tier artists like Vintage Culture, Don Diablo, Chris Avantgarde, Lilly Palmer, MORTEN, Bassjackers, and GENESI and has support from Binance, OKX, Bitget, and Polygon. RaveDAO is redefining live entertainment in Web3 and has active partnerships with 1001Tracklists, AMF, and Warner Music.  Beyond the dance floor, RaveDAO channels energy and attention toward impact. In 2025 alone, proceeds from its events helped restore sight to 400+ cataract patients in Nepal and fund over 150 meditation programs across the U.S.

RaveDAO

RaveDAO is experiencing massive volatility fueled by a short squeeze, aggressive whale activity, and speculation surrounding upcoming real-world music events and potential high-profile partnerships. While proponents point to its buyback-and-burn mechanics and growing event ecosystem as long-term catalysts, critics are sounding alarms about potential market manipulation and the risks of a rapid pump-and-dump cycle.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is facing significant investor scrutiny as shares endure a prolonged period of downward volatility, despite the company highlighting new AI-driven utility and supply chain platform announcements. The community is actively debating whether the stock's recent performance represents an attractive entry point for a long-term AI infrastructure play or if mounting debt and competitive pressures from new AI entrants will continue to weigh on the share price.

AT&T, Inc. is a holding company, which engages in the provision of telecommunications and technology services. It operates through the Communications and Latin America segments. The Communications segment offers wireless, wireline telecom, and broadband services to businesses and consumers located in the US and businesses globally. The Latin America segment provides wireless services and equipment in Mexico. The company was founded in 1983 and is headquartered in Dallas, TX.

AT&T, Inc.

AT&T Inc

AT&T is trending as investors weigh strong fourth-quarter earnings and a robust 2026 outlook against long-term debt concerns and stiff industry competition. The community is actively debating the stock's stability as a defensive "safe haven" play while monitoring strategic network investments and upcoming share repurchases.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is experiencing a massive rally and high trading volume driven by multiple strategic partnerships, including major infrastructure deals with Google and Elon Musk's Terafab project. While the stock has reached multi-year highs and captured significant investor momentum, community discussion remains polarized between bullish long-term sentiment regarding Intel's turnaround and bearish concerns about its premium valuation and overextended technical indicators.

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Revolution Medicines Inc

Revolution Medicines is driving significant market attention as its daraxonrasib trial for pancreatic cancer shows strong survival benefits, positioning the company as a potential leader in the targeted oncology space. The community is actively debating its high valuation and M&A potential, with many investors focusing on the company's robust cash position and the massive unmet need for new treatments in the pancreatic cancer market.

ImageneBio, Inc. is a clinical-stage biotechnology company that boldly imagines a world where patients can be free from the burden of grievous immunological/autoimmune and inflammatory (I&I) diseases. It focuses on the development of new medicines with differentiated profiles that can effectively control and change the course of I&I diseases for affected patients, treat their symptoms, and improve quality of life. The company was founded in February 2016, and is headquartered in San Diego, CA.

ImageneBio Inc.

ImageneBio, Inc.

ImageneBio is generating significant investor attention following a 30 million dollar private placement aimed at advancing their clinical pipeline for hair loss and skin disease treatments. While some traders are focused on the stock's potential for a breakout based on its current valuation relative to cash, others are debating the long-term clinical risks and the impact of the dilutive financing on the share price.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Short Interest in Ovid Therapeutics (NASDAQ:OVID) Increases By 71.2%

Ovid Therapeutics (NASDAQ:OVID - Get Free Report) saw a large increase in short interest during the month of March. As of March 31st, there was short interest totaling 9,337,824 shares, an increase...

HC Wainwright Issues Positive Forecast for OVID Earnings

Ovid Therapeutics (NASDAQ:OVID - Free Report) - Equities research analysts at HC Wainwright boosted their Q2 2026 earnings per share (EPS) estimates for Ovid Therapeutics in a research note issued on...

Ovid Therapeutics (NASDAQ:OVID) Price Target Raised to $4.00

HC Wainwright boosted their price objective on shares of Ovid Therapeutics from $2.00 to $4.00 and gave the company a "buy" rating in a research report on Thursday...

Ovid Therapeutics' (OVID) Buy Rating Reaffirmed at BTIG Research

BTIG Research reiterated a "buy" rating and issued a $4.00 price objective on shares of Ovid Therapeutics in a report on Thursday...

Lifesci Capital Has Negative Estimate for OVID Q1 Earnings

Ovid Therapeutics (NASDAQ:OVID - Free Report) - Analysts at Lifesci Capital dropped their Q1 2026 earnings per share estimates for Ovid Therapeutics in a research note issued to investors on Tuesday...

Ovid Therapeutics (NASDAQ:OVID) Receives Consensus Recommendation of "Buy" from Brokerages

Shares of Ovid Therapeutics (NASDAQ:OVID - Get Free Report) have received an average rating of "Buy" from the nine research firms that are currently covering the company, Marketbeat Ratings reports...

Wall Street Zen Upgrades Ovid Therapeutics (NASDAQ:OVID) to Hold

Wall Street Zen raised shares of Ovid Therapeutics from a "sell" rating to a "hold" rating in a research note on Saturday...

Wedbush Forecasts Strong Price Appreciation for Ovid Therapeutics (NASDAQ:OVID) Stock

Wedbush lifted their target price on Ovid Therapeutics from $5.00 to $7.00 and gave the stock an "outperform" rating in a research note on Friday...

Ovid Therapeutics Q4 Earnings Call Highlights

Ovid Therapeutics (NASDAQ:OVID) outlined new pipeline and financing updates alongside its fourth-quarter and full-year 2025 results, highlighting regulatory clearance in Australia for its KCC2 direct...

Here's Why Ovid Therapeutics Stock Popped Higher Today

Key PointsOV329 may be safer and more potent than existing treatments...

Ovid Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During on April 1, 2014 and is headquartered in New York, NY.

Ovid Therapeutics Inc

Start of a real move higher

Dead cat - we retest the lows

Show me the results

Software is bouncing hard today. Is this the start of a sustained recovery or just a dead cat bounce before we retest the lows?

OVID
Ovid Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest OVID News

OVIDOvid Therapeutics Inc